Verona Pharma plc (VRP.L) (LON:VRP) Share price breaks below 200-day moving average of $50.16
Verona Pharma plc (VRP.L) (LON:VRP – Get Rating) share price fell below its 200-day moving average during Friday’s session. The stock has a 200-day moving average of 50.16 GBX ($0.60) and is trading as low as 50 GBX ($0.60). Shares of Verona Pharma plc (VRP.L) last traded at GBX 55 ($0.66), with volume traded at 70,791 shares.
Verona Pharma plc (VRP.L) Share Performance
The company has a quick ratio of 2.47, a current ratio of 2.99 and a debt ratio of 6.85. The company’s 50-day rolling average price is 55 GBX and its 200-day rolling average price is 50.16 GBX. The company has a market capitalization of £228 million and a P/E ratio of -1.68.
Verona Pharma plc (VRP.L) Company Profile
(Get an assessment)
Verona Pharma plc, a clinical-stage biopharmaceutical company, develops and markets therapeutic products to treat respiratory diseases. The Company’s product candidate is RPL554, a dual inhaled phosphodiesterase 3 and 4 enzyme inhibitor that has completed Phase I and II clinical trials that acts as a bronchodilator and anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease. , cystic fibrosis , chronic asthma and allergic rhinitis.
Get daily news and reviews for Verona Pharma plc (VRP.L) – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Verona Pharma plc (VRP.L) and related companies with MarketBeat.com’s free daily email newsletter .